Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.

A multicentre randomised phase III trial in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) was undertaken to compare the therapeutic activity and toxicity of a cisplatin/carboplatin-etoposide-vinorelbine combination with that of a cisplatin-etoposide regimen. Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Comella, P., Frasci, G., De Cataldis, G., Panza, N., Cioffi, R., Curcio, C., Belli, M., Bianco, A., Ianniello, G., Maiorino, L., Della Vittoria, M., Perchard, J., Comella, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077209/
https://www.ncbi.nlm.nih.gov/pubmed/8956797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077209/
https://www.ncbi.nlm.nih.gov/pubmed/8956797

Ejemplares similares